{"transactions":[{"id":3978786,"issuer":{"id":5216,"kind":"organization","name":"ASSEMBLY BIOSCIENCES, INC."},"owners":[{"id":167933,"kind":"person","name":"Rollins Thomas E","position":1,"cik":"0001667428","reported_name":"Rollins Thomas E","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Development Officer"}}],"security":"Stock Option (right to buy)","published_at":"2018-03-30T18:30:12.000Z","date":"2018-03-29","kind":"grant","acquired":true,"shares":7500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Grant of stock options. The stock options vest over four years, assuming continuous service on each vesting date, as follows: 25% shall vest on the first anniversary of the date of grant, March 29, 2019; and the remaining 75% shall vest in 36 equal monthly installments, with the options becoming fully vested on March 29, 2022."}],"balance_after":7500,"derivative":{"exercise_price":49.14,"expiration_date":"2028-03-29","underlying":"Common Stock","underlying_shares":7500},"source":{"system":"sec-edgar","filing":"0001144204-18-018348","document":"tv490032_4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1667428/000114420418018348/tv490032_4.xml","form_type":"4"}},{"id":3978785,"issuer":{"id":5216,"kind":"organization","name":"ASSEMBLY BIOSCIENCES, INC."},"owners":[{"id":167933,"kind":"person","name":"Rollins Thomas E","position":1,"cik":"0001667428","reported_name":"Rollins Thomas E","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Development Officer"}}],"security":"Common Stock","published_at":"2018-03-30T18:30:12.000Z","date":"2018-03-29","kind":"grant","acquired":true,"shares":3750,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Grant of restricted stock units. The restricted stock units vest in four equal installments, assuming continuous service on each vesting date, as follows: March 29, 2019; March 29, 2020; March 29, 2021; and March 29, 2022."}],"balance_after":3750,"source":{"system":"sec-edgar","filing":"0001144204-18-018348","document":"tv490032_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1667428/000114420418018348/tv490032_4.xml","form_type":"4"}},{"id":4367019,"issuer":{"id":5216,"kind":"organization","name":"ASSEMBLY BIOSCIENCES, INC."},"owners":[{"id":167933,"kind":"person","name":"Rollins Thomas E","position":1,"cik":"0001667428","reported_name":"Rollins Thomas E","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Stock Option (Right to Buy)","published_at":"2017-03-31T16:12:31.000Z","date":"2017-03-29","kind":"grant","acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options vest over two years as follows: 50% shall vest on the first anniversary of the date of grant, March 29, 2018; and the remaining 50% shall vest in 12 equal monthly installments, with the options becoming fully vested on March 29, 2019."}],"balance_after":10000,"derivative":{"exercise_price":25.34,"expiration_date":"2027-03-29","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001144204-17-018193","document":"v463066_4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1667428/000114420417018193/v463066_4.xml","form_type":"4"}}]}